New Castle, DE, United States of America

Christopher A Teleha


Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1994-1999

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christopher A. Teleha

Introduction

Christopher A. Teleha is a notable inventor based in New Castle, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance neurotransmitter release. With a total of 10 patents to his name, Teleha's work has the potential to impact the treatment of various neurological conditions.

Latest Patents

Among his latest patents, Teleha has developed compounds that enhance the release of the neurotransmitter acetylcholine. These compounds may be beneficial in treating diseases such as Alzheimer's disease, where subnormal levels of this neurochemical are present. His invention describes pharmaceutical compositions and methods of treatment that utilize these compounds. Additionally, he has worked on compounds that block neuronal M-channels, which can be useful for treating conditions involving neurotransmitter deficiencies, traumatic brain injury, or the depressive phase of bipolar disorder.

Career Highlights

Teleha is currently associated with the DuPont Merck Pharmaceutical Company, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential therapeutic applications and contributions to neuroscience.

Collaborations

Some of his notable coworkers include Wendell W. Wilkerson and Richard A. Earl, who have collaborated with him on various projects within the pharmaceutical field.

Conclusion

Christopher A. Teleha's innovative work in developing compounds for neurotransmitter release and neuronal M-channel blockade showcases his commitment to advancing medical science. His contributions have the potential to improve the lives of individuals suffering from neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…